Argos Therapeutics

Argos Therapeutics, Inc. is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases and transplantation rejection. The company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells - the master switch that turns the immune system on or off.

Durham, US
136 (est)+21%
Argos Therapeutics was founded in 1997 and is headquartered in Durham, US

Argos Therapeutics Locations

Durham, US

Argos Therapeutics Metrics

Argos Therapeutics Summary

Market capitalization

$208 M

Closing share price

Argos Therapeutics's current market capitalization is $208 M.

Argos Therapeutics Financials

Argos Therapeutics's revenue is $518 K in FY, 2015 which is 73.74% decrease from the previous period.
FY, 2014FY, 2015


$1.97 M$518 K

Operating income

$-52.1 M$-72.5 M

Operating expense total

$54.1 M$73.1 M

Net Income

$-53.3 M$-74.8 M

Operating cash flow

$3.93 M$-31.1 M

    Argos Therapeutics Market Value History

    Argos Therapeutics Online Presence

    Argos Therapeutics News

    Argos Therapeutics Company Life

    You may also be interested in